A website dedicated to the world of M&A – transactions, ideas, insights and other relevant M&A-related resources.
In our ever-changing business environment, companies are continually seeking ways to maintain or enhance their competitive edge. Historically, Research and Development (R&D) was a key line item for innovative companies to remain ahead of their competition. Another strategy that has become increasingly…
A crisis is never fun, this one even less as this economic downturn has risen from a health concern. On top of people losing their jobs, businesses closing, and loads of wealth suddenly being wiped out, we also have a life-threatening virus…
Other People’s Money – OPM – is a crucial component for improved performance. Using debt to acquire productive assets allows for higher returns on your invested capital. The logic is sound and the returns on invested capital are, indeed, attractive. Similarly, publicly-traded…
In general, Mergers and Acquisitions have been an excellent tool to gain scale rapidly, buy market shares or simply increase geographical reach, just to name a few of the advantages. M&A has also been a proven way to acquire talent, technology, new…
We’ve discussed “Deal Fatigue” earlier and explained how it accumulates over the courses of an M&A process as a result of the complexity of these transactions. Time is passing by, what do we have to show for it? Time flies when you’re…
Mergers and Acquisitions processes take time and are complex. It is not uncommon for such processes to take a year or more from first conversation to closing of a deal. There are lots of moving parts to take into consideration and, usually,…
Generating and accumulating wealth is a difficult task. It generally requires the right combination of efforts, risks and time. Preserving this wealth is a whole other set of challenges, especially for entrepreneurs who have been focused on successfully growing and managing their businesses…
The big M&A news of today is the merger of French Essilor and Italian Luxottica into a $50Bn Eyewear leader. This transaction makes a lot of sense, Luxottica and Essilor are essentially two behemoths in two segments of an otherwise fragmented industry. Being…
Companies get acquired everyday. Sometimes, competitors do it to dominate a market, expand their portfolio or simply remove a cumbersome player. Sometimes, financial buyers do it because they identified areas of improvement, growth opportunities, or simply a sustainable business model that they…
Being involved in a merger or acquisition is almost always complex, irrespective of where you stand. Be it from the buyer, seller, intermediary or adviser’s standpoint, there are many aspects to a transaction and incentives that are oftentimes very different based on…
As financial advisor, I have met with numerous business owners over the past decade, sometimes on the sell-side, others on the buy-side or even pitching our services to them. Some companies just project success in everything they do. A good business model, a solid brand, numerous…
With Abbott’s () $25Bn bid for St. Jude Medical () made official on Thursday, and with this being only yet one more multi-billion-Dollar bid in the space this year, one is left wondering how much longer will this sector be able to…